NR
Nagendra Ramachndrappa
About Nagendra Ramachndrappa
Data last updated:
Nagendra Ramachndrappa has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Starcine Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Starcine Pharmaceutical Private Limited at ₹31.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Starcine Pharmaceutical Private Limited U24290KA2020PTC141585 | Director | 20 Jan 2021 | 2020 | ₹31.2 Lakh (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nagendra Ramachndrappa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagendra Ramachndrappa
Nagendra Ramachndrappa has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Starcine Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Starcine Pharmaceutical Private Limited at ₹31.2 Lakh (FY 2025).
Nagendra Ramachndrappa is associated with 1 company as Director, including Starcine Pharmaceutical Private Limited (₹31.2 Lakh).
Nagendra Ramachndrappa has expertise in General Business.
Nagendra Ramachndrappa has 5 years in corporate governance.
By reported revenue, the largest current company of Nagendra Ramachndrappa is Starcine Pharmaceutical Private Limited, with revenue of ₹31.2 Lakh (FY 2025).
Nagendra Ramachndrappa currently holds positions at 1 company: Starcine Pharmaceutical Private Limited (₹31.2 Lakh).